These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 15459212

  • 1. Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastoma.
    Katzenstein HM, Cohn SL, Shore RM, Bardo DM, Haut PR, Olszewski M, Schmoldt J, Liu D, Rademaker AW, Kletzel M.
    J Clin Oncol; 2004 Oct 01; 22(19):3909-15. PubMed ID: 15459212
    [Abstract] [Full Text] [Related]

  • 2. Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma.
    Matthay KK, Edeline V, Lumbroso J, Tanguy ML, Asselain B, Zucker JM, Valteau-Couanet D, Hartmann O, Michon J.
    J Clin Oncol; 2003 Jul 01; 21(13):2486-91. PubMed ID: 12829667
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy.
    Kushner BH, Yeh SD, Kramer K, Larson SM, Cheung NK.
    J Clin Oncol; 2003 Mar 15; 21(6):1082-6. PubMed ID: 12637474
    [Abstract] [Full Text] [Related]

  • 5. The prognostic impact of functional imaging with (123)I-mIBG in patients with stage 4 neuroblastoma >1 year of age on a high-risk treatment protocol: results of the German Neuroblastoma Trial NB97.
    Schmidt M, Simon T, Hero B, Schicha H, Berthold F.
    Eur J Cancer; 2008 Jul 15; 44(11):1552-8. PubMed ID: 18424129
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical impact and prognostic value of metaiodobenzylguanidine imaging in children with metastatic neuroblastoma.
    Perel Y, Conway J, Kletzel M, Goldman J, Weiss S, Feyler A, Cohn SL.
    J Pediatr Hematol Oncol; 1999 Jul 15; 21(1):13-8. PubMed ID: 10029806
    [Abstract] [Full Text] [Related]

  • 8. Metastatic neuroblastoma in children older than one year: prognostic significance of the initial metaiodobenzylguanidine scan and proposal for a scoring system.
    Suc A, Lumbroso J, Rubie H, Hattchouel JM, Boneu A, Rodary C, Robert A, Hartmann O.
    Cancer; 1996 Feb 15; 77(4):805-11. PubMed ID: 8616776
    [Abstract] [Full Text] [Related]

  • 9. Iodine-123 metaiodobenzylguanidine scintigraphy scoring allows prediction of outcome in patients with stage 4 neuroblastoma: results of the Cologne interscore comparison study.
    Decarolis B, Schneider C, Hero B, Simon T, Volland R, Roels F, Dietlein M, Berthold F, Schmidt M.
    J Clin Oncol; 2013 Mar 01; 31(7):944-51. PubMed ID: 23341514
    [Abstract] [Full Text] [Related]

  • 10. Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group.
    Yanik GA, Parisi MT, Shulkin BL, Naranjo A, Kreissman SG, London WB, Villablanca JG, Maris JM, Park JR, Cohn SL, McGrady P, Matthay KK.
    J Nucl Med; 2013 Apr 01; 54(4):541-8. PubMed ID: 23440556
    [Abstract] [Full Text] [Related]

  • 11. Incorporation of high-dose 131I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study.
    Lee JW, Lee S, Cho HW, Ma Y, Yoo KH, Sung KW, Koo HH, Cho EJ, Lee SK, Lim DH.
    J Hematol Oncol; 2017 May 16; 10(1):108. PubMed ID: 28511709
    [Abstract] [Full Text] [Related]

  • 12. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
    Claudiani F, Stimamiglio P, Bertolazzi L, Cabria M, Conte M, Villavecchia GP, Garaventa A, Lanino E, De Bernardi B, Scopinaro G.
    Q J Nucl Med; 1995 Dec 16; 39(4 Suppl 1):21-4. PubMed ID: 9002744
    [Abstract] [Full Text] [Related]

  • 13. Persistent positive metaiodobenzylguanidine scans after autologous peripheral blood stem cell transplantation may indicate maturation of stage 4 neuroblastoma.
    Okamoto Y, Kodama Y, Nishikawa T, Rindiarti A, Tanabe T, Nakagawa S, Yoshioka T, Takumi K, Kaji T, Kawano Y.
    Pediatr Hematol Oncol; 2017 Apr 16; 34(3):157-164. PubMed ID: 28976242
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma.
    Messina JA, Cheng SC, Franc BL, Charron M, Shulkin B, To B, Maris JM, Yanik G, Hawkins RA, Matthay KK.
    Pediatr Blood Cancer; 2006 Dec 16; 47(7):865-74. PubMed ID: 16444675
    [Abstract] [Full Text] [Related]

  • 15. What is the prognostic value of osteomedullary uptake on MIBG scan in neuroblastoma patients under one year of age?
    Labreveux de Cervens C, Hartmann O, Bonnin F, Couanet D, Valteau-Couanet D, Lumbroso J, Behar C, Martelli H, Lemerele J.
    Med Pediatr Oncol; 1994 Dec 16; 22(2):107-14. PubMed ID: 8259095
    [Abstract] [Full Text] [Related]

  • 16. Radiation therapy to the primary and postinduction chemotherapy MIBG-avid sites in high-risk neuroblastoma.
    Mazloom A, Louis CU, Nuchtern J, Kim E, Russell H, Allen-Rhoades W, Krance R, Paulino AC.
    Int J Radiat Oncol Biol Phys; 2014 Nov 15; 90(4):858-62. PubMed ID: 25245583
    [Abstract] [Full Text] [Related]

  • 17. The role of 131 iodine-metaiodobenzylguanidine scanning in the correlative imaging of patients with neuroblastoma.
    Andrich MP, Shalaby-Rana E, Movassaghi N, Majd M.
    Pediatrics; 1996 Feb 15; 97(2):246-50. PubMed ID: 8584386
    [Abstract] [Full Text] [Related]

  • 18. Response-adapted consolidation therapy strategy for patients with metastatic high-risk neuroblastoma: Results of the SMC NB-2014 study.
    Seo ES, Lee JW, Cho HW, Ju HY, Cho YS, Lee S, Moon SH, Yoo KH, Lim DH, Sung KW.
    Pediatr Blood Cancer; 2024 Sep 15; 71(9):e31173. PubMed ID: 38965702
    [Abstract] [Full Text] [Related]

  • 19. 131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II study.
    Yanik GA, Villablanca JG, Maris JM, Weiss B, Groshen S, Marachelian A, Park JR, Tsao-Wei D, Hawkins R, Shulkin BL, Jackson H, Goodarzian F, Shimada H, Courtier J, Hutchinson R, Haas-Koga D, Hasenauer CB, Czarnecki S, Katzenstein HM, Matthay KK.
    Biol Blood Marrow Transplant; 2015 Apr 15; 21(4):673-81. PubMed ID: 25639769
    [Abstract] [Full Text] [Related]

  • 20. Treatment of advanced neuroblastoma in children over 1 year of age: the critical role of ¹³¹I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen.
    Mastrangelo S, Rufini V, Ruggiero A, Di Giannatale A, Riccardi R.
    Pediatr Blood Cancer; 2011 Jul 01; 56(7):1032-40. PubMed ID: 21344615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.